1 |
用于生产聚-4-羟基丁酸酯的遗传工程微生物 |
CN201380026228.1 |
2013-03-04 |
CN104321427A |
2015-01-28 |
W·R·法默; C·W·J·麦克查利彻; T·M·拉姆塞尔; Z·张; D-E·常; J·比克迈耶; J·比利; C·莫泽 |
本文描述了用于生产聚-4-羟基丁酸酯和4-碳产物的方法和遗传工程宿主。 |
2 |
Fumarate reductases |
US15103237 |
2014-12-12 |
US09944905B2 |
2018-04-17 |
René Marcel De Jong; Zheng Zhao; Ben Den Dulk; Remko Tsjibbe Winter |
The present invention relates to a variant polypeptide having fumarate reductase activity, which has modified NADP(H)-dependent and/or NAD(H)-dependent activity as compared with a reference polypeptide having fumarate reductase activity. Such a variant may be overexpressed in a host cell in order to improve production of a dicarboxylic acid. |
3 |
L-malate production by metabolically engineered escherichia coli |
US13819773 |
2011-09-01 |
US09187772B2 |
2015-11-17 |
Xueli Zhang; Xuan Wang; Keelnatham T. Shanmugam; Lonnie O'Neal Ingram |
A process for the production of malic acid in commercially significant quantities from the carbon compounds by genetically modified bacterial strains (GMBS; also referred to as biocatalysts or genetically modified microorganisms) is disclosed. Microorganisms suitable for the production of malic acid can be cultured in one or two-step processes as disclosed herein. |
4 |
ELECTROCHEMICAL BIOREACTOR MODULE AND ENGINEERED METABOLIC PATHWAYS FOR 1- BUTANOL PRODUCTION WITH HIGH CARBON EFFICIENCY |
EP16756175 |
2016-02-23 |
EP3262179A4 |
2018-07-11 |
DODDS DAVID R; ARMIGER WILLIAM B; KOFFAS MATTHEOS |
A combination of an electrochemical device for delivering reducing equivalents to a cell, and engineered metabolic pathways within the cell capable of utilizing the electrochemically provided reducing equivalents is disclosed. Such a combination allows the production of commodity chemicals by fermentation to proceed with increased carbon efficiency. |
5 |
Compositions and Methods for Succinate Production |
US15386506 |
2016-12-21 |
US20170107526A1 |
2017-04-20 |
Kenneth R. FINLEY; Jeanette M. HURYTA; Beth M. MASTEL; Thomas W. MCMULLIN; Gregory M. POYNTER; Brian J. RUSH; Arlene M. FOSMER; Vernon L. MCINTOSH, JR.; Keith M. BRADY; Kevin T. WATTS |
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate. |
6 |
Compositions and methods for succinate production |
US13981517 |
2012-01-25 |
US09605285B2 |
2017-03-28 |
Kenneth R. Finley; Jeanette M. Huryta; Beth M. Mastel; Thomas W. McMullin; Gregory M. Poynter; Brian J. Rush; Kevin T. Watts; Arlene M. Fosmer; Vernon L. McIntosh, Jr.; Keith M. Brady |
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate. |
7 |
COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION |
EP12740007 |
2012-01-25 |
EP2668281A4 |
2015-08-26 |
CARGILL INCORPORATED; BIOAMBER S A S |
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate. |
8 |
Electrochemical Bioreactor Module and Engineered Metabolic Pathways for 1-Butanol Production with High Carbon Efficiency |
US15552647 |
2016-02-23 |
US20180037914A1 |
2018-02-08 |
David R. Dodds; William B. Armiger; Mattheos Koffas |
A combination of an electrochemical device for delivering reducing equivalents to a cell, and engineered metabolic pathways within the cell capable of utilizing the electrochemically provided reducing equivalents is disclosed. Such a combination allows the production of commodity chemicals by fermentation to proceed with increased carbon efficiency. |
9 |
FUMARATE REDUCTASES |
US15103237 |
2014-12-12 |
US20160319245A1 |
2016-11-03 |
René Marcel DE JONG; Zheng ZHAO; Ben DEN DULK; Remko Tsjibbe WINTER |
The present invention relates to a variant polypeptide having fumarate reductase activity, which has modified NADP(H)-dependent and/or NAD(H)-dependent activity as compared with a reference polypeptide having fumarate reductase activity. Such a variant may be overexpressed in a host cell in order to improve production of a dicarboxylic acid. |
10 |
Genetically Engineered Microorganisms for the Production of Poly-4-Hydroxybutyrate |
US14386728 |
2013-03-04 |
US20150159184A1 |
2015-06-11 |
Thomas M. Ramseier; Christopher W.J. McChalicher; William R. Farmer; Zhigang Zhang; Dong-Eun Chang; Jeff Bickmeier; Julie Beaulieu; Catherine Morse |
Methods and genetically engineered hosts for the production of poly-4-hydroxybutrate and 4-carbon products are described herein. |
11 |
COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION |
US13981517 |
2012-01-25 |
US20130302866A1 |
2013-11-14 |
Kenneth R. Finley; Jeanette M. Huryta; Beth M. Mastel; Thomas W. McMullin; Gregory M. Poynter; Brian J. Rush; Kevin T. Watts; Arlene M. Fosmer; Vernon L. McIntosh, JR.; Keith M. Brady |
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate. |
12 |
L-MALATE PRODUCTION BY METABOLICALLY ENGINEERED ESCHERICHIA COLI |
US13819773 |
2011-09-01 |
US20130157330A1 |
2013-06-20 |
Xueli Zhang; Xuan Wang; Keelnatham T. Shanmugam; Lonnie O'Neal Ingram |
A process for the production of malic acid in commercially significant quantities from the carbon compounds by genetically modified bacterial strains (GMBS; also referred to as biocatalysts or genetically modified microorganisms) is disclosed. Microorganisms suitable for the production of malic acid can be cultured in one or two-step processes as disclosed herein. |
13 |
ELECTROCHEMICAL BIOREACTOR MODULE AND ENGINEERED METABOLIC PATHWAYS FOR 1- BUTANOL PRODUCTION WITH HIGH CARBON EFFICIENCY |
EP16756175.2 |
2016-02-23 |
EP3262179A1 |
2018-01-03 |
DODDS, David R.; ARMIGER, William B.; KOFFAS, Mattheos |
A combination of an electrochemical device for delivering reducing equivalents to a cell, and engineered metabolic pathways within the cell capable of utilizing the electrochemically provided reducing equivalents is disclosed. Such a combination allows the production of commodity chemicals by fermentation to proceed with increased carbon efficiency. |
14 |
GENETICALLY ENGINEERED MICROORGANISMS FOR THE PRODUCTION OF POLY-4-HYDROXYBUTYRATE |
EP13710245.5 |
2013-03-04 |
EP2828383A1 |
2015-01-28 |
FARMER, William, R.; MCCHALICHER, Christopher, W.J.; RAMSEIER, Thomas, M.; ZHANG, Zhigang; CHANG, Dong-Eun; BICKMEIER, Jeff; BEAULIEU, Julie; MORSE, Catherine |
Methods and genetically engineered hosts for the production of poly-4-hydroxybutrate and 4-carbon products are described herein. |
15 |
COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION |
EP12740007.5 |
2012-01-25 |
EP2668281A2 |
2013-12-04 |
Cargill, Incorporated; BioAmber S.A.S. |
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate. |
16 |
COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION |
PCT/US2012022612 |
2012-01-25 |
WO2012103261A3 |
2012-11-22 |
FINLEY KENNETH R; HURYTA JEANETTE M; MASTEL BETH M; MCMULLIN THOMAS W; POYNTER GREGORY M; RUSH BRIAN J; WATTS KEVIN T; FOSMER ARLENE M; MCINTOSH VERNON L JR; BRADY KEITH M |
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate. |
17 |
FUMARATE REDUCTASES |
PCT/EP2014077638 |
2014-12-12 |
WO2015086839A9 |
2016-09-09 |
JONG DE RENÉ MARCEL; ZHAO ZHENG; DULK DEN BEN; WINTER REMKO TSJIBBE |
The present invention relates to a variant polypeptide having fumarate reductase activity, which has modified NADP(H)-dependent and/or NAD(H)-dependent activity as compared with a reference polypeptide having fumarate reductase activity. Such a variant may be overexpressed in a host cell in order to improve production of a dicarboxylic acid. |
18 |
L-MALATE PRODUCTION BY METABOLICALLY ENGINEERED ESCHERICHIA COLI |
PCT/US2011050146 |
2011-09-01 |
WO2012031079A2 |
2012-03-08 |
ZHANG XUELI; WANG XUAN; SHANMUGAM KEELNATHAM T; INGRAM LONNIE O'NEAL |
A process for the production of malic acid in commercially significant quantities from the carbon compounds by genetically modified bacterial strains (GMBS; also referred to as biocatalysts or genetically modified microorganisms) is disclosed. Microorganisms suitable for the production of malic acid can be cultured in one or two-step processes as disclosed herein. |